Lummy obtained two drug registration certificates
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Lummy announced that the company has received the Drug Registration Certificates for two medications: Nicorandil Tablets (Specification: 5mg) and Ketorolac Tromethamine Injection (Specification: 1ml: 30mg) approved by the National Medical Products Administration. The announcement indicates that Nicorandil Tablets are used for the treatment of angina pectoris. Ketorolac Tromethamine Injection is suitable for the short-term treatment of moderate to severe acute postoperative pain
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments